The invention provides a new type of oral Chinese herbal decoction with a new blood exhausted powder. The preparation process is as follows: 1) the raw material of the blood is tested, the net, the crushing, the intermediate; the 2) inspection intermediate, the irradiation sterilization of the electron beam after packing; 3) the finished product standard test, the finished product after packing, step 1 described, 1), The following crushing conditions are as follows: in the D level clean area, the vacuum pulverization technique is used to crush the raw material of the Draco Draco to 80 200 orders; in step 2) the irradiation dose of electron beam irradiation is 3 and 10 kGy. The invention can increase the total amount of the water extract of the fine powder of the Chinese Pharmacopoeia (100 orders) and the total amount of water soluble in the water extract from the Chinese Pharmacopoeia (Chinese Pharmacopoeia) by more than 18%. The results of microbial limit test can fully conform to the standard of the related direct oral drink.
【技术实现步骤摘要】
血竭粉直接口服中药饮片
本专利技术涉及一种血竭粉直接口服中药饮片,属于医药
技术介绍
淤血经闭、痛经,产后瘀阻;症瘕痞块,胸腹刺痛;跌打损伤,淤血肿痛;外伤出血,溃疡不敛是中医临床上极为常见的诊断病症。血竭是活血定痛、化淤止血、生肌敛疮首选名贵中药,也是收载于《中国药典》2010版一部的重要中药之一。血竭的用法是既能外用亦可内服。最近的天然产物化学研究表明,血竭含有红色树脂中含血竭红素(dracorubin),血竭素(dracorhodin),去甲基血竭红素(nordracorubin),去甲基血竭素(nordracorhodin),(2S)-5-甲氧基-6-甲基黄烷-7-醇[(2S)-5-methoxy-6-methyl-flavan-7-ol],(2S)-5-甲氧基黄烷-7-醇[(2S)-5-methoxy-flavan-7-ol],2,4-二羟基-5-甲基-6-甲氧基查二酮(2,4-dihydroxy-5-methyl-6-Methoxy-chalocone),2,4-二羟基-6-甲氧基查耳酮(2,4-dihydroxy-6-methoxychalcone);另含松脂酸(pimaricacid)、异松脂酸(isopimaricacid),松香酸(abieticacid)、去氢松香酸(degydroabieticacid),香松胶脂酸(sandaracopimaricacid),齐墩果酸(oleanolicacid),石竹醛(oleanonicaldehyde)及熊果醛(ursonicaldehyde)等。现代药理研究显示,血竭具有以下药理作 ...
【技术保护点】
1.血竭粉直接口服中药饮片,其特征在于,其制备工艺如下:1)将血竭原药材检验、净制、粉碎,得到中间体;2)检验中间体,包装后进行电子束辐照灭菌;3)进行成品标准检验,包装后得到成品;所述的步骤1)中,粉碎条件如下:在D级洁净区,应用吸尘式低温粉碎技术,将血竭原药材粉碎成80‑200目;所述的步骤2)中,电子束辐照灭菌的照射剂量为3‑10 kGy。
【技术特征摘要】
1.血竭粉直接口服中药饮片,其特征在于,其制备工艺如下:1)将血竭原药材检验、净制、粉碎,得到中间体;2)检验中间体,包装后进行电子束辐照灭菌;3)进行成品标准检验,包装后得到成品;所述的步骤1)中,粉碎条件如下:在D级洁净区,应用吸尘式低温粉碎技术,将血竭原药材粉碎成80-200目;所述的步骤2)中,电子束...
【专利技术属性】
技术研发人员:邓京振,周建平,
申请(专利权)人:江苏苏轩堂药业有限公司,
类型:发明
国别省市:江苏,32
还没有人留言评论。发表了对其他浏览者有用的留言会获得科技券。